Comparative Bioavailability of Sublingual TNX-102, Oral and Intravenous Cyclobenzaprine in Healthy Adults
Condition: Healthy AdultsInterventions: Drug: SL TNX-102 2.4 mg at pH 3.5; Drug: SL TNX-102 2.4 mg at pH 7.1; Drug: Cyclobenzaprine Tablet; Drug: Cyclobenzaprine IVSponsor: Tonix Pharmaceuticals, Inc.Completed - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cyclobenzaprine | Research